Gallium-68 dotatate
Approved Use: indicated for use with PET imaging for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients
Dose (Adult and Pediatric): 0.054 mCi/kg; maximum = 5.4 mCi
Brand Name: NETSPOT™
Manufacturer: Advanced Accelerator Applications (AAA)
Package Insert
How Supplied: multi-dose kit containing two vials
Patient Guide
Press Release 2 JUN 2016 (Letter from manufacturer - FDA approval)
Press Release 1 JUN 2016 (FDA approval)
Clinical Guidelines:
Dose (Adult and Pediatric): 0.054 mCi/kg; maximum = 5.4 mCi
Brand Name: NETSPOT™
Manufacturer: Advanced Accelerator Applications (AAA)
Package Insert
How Supplied: multi-dose kit containing two vials
- Vial 1 (light-blue cap): reaction vial with lyophilized powder containing 40 mcg dotatate
- Vial 2 (yellow cap): buffer vial containing 1 mL of reaction buffer solution
- Eckert & Ziegler GalliaPharm® Ge-68/Ga-68 generator
- IRE ELiT Galli Eo™ Ge-68/Ga-68 generator
Patient Guide
Press Release 2 JUN 2016 (Letter from manufacturer - FDA approval)
Press Release 1 JUN 2016 (FDA approval)
Clinical Guidelines:
- SNMMI Procedure Standard/EANM Practice Guideline for SSTR Receptor PET: Imaging Neuroendocrine Tumors (2022)
- EANM Practice Guideline/SNMMI Procedure Standard for Radionuclide Imaging of Pheochromocytoma and Paraganglioma (2019)
- ACR Practice Parameter for the Performance of Gallium-68 DOTATATE PET/CT for Neuroendocrine Tumors (2018)